NCT02024841View on ClinicalTrials.gov

Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2018

Conditions
Gastric CancerPeritoneal Carcinomatosis
Interventions
DRUG

Intraperitoneal docetaxel

Intraperitoneal docetaxel, intravenous cisplatin and oral TS-ONE every 3 weeks for 3 cycles then stop

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

lead

The University of Hong Kong

OTHER

NCT02024841 - Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis | Biotech Hunter | Biotech Hunter